As previously reported, Craig-Hallum initiated coverage of Cryoport (CYRX) with a Buy rating and $15 price target CryoPort is a specialized logistics provider serving the C> market. The firm believes that the pipeline ramp, adjusted EBITDA turning positive in the second half of 2026, regulatory tailwinds, and a clean balance sheet are all underestimated by the Street. This could represent one of the most asymmetric setups in the C> space, Craig-Hallum adds.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CYRX:
- Cryoport initiated with a Buy at Craig-Hallum
- Cryoport Earnings Call Highlights Pipeline-Fueled Growth
- Cryoport: Strengthening Growth Momentum and Path to Profitability Support Buy Rating
- CryoPort: Raised Price Target on Strong Q4 Beat, Upbeat 2026 Outlook, and Path to Positive EBITDA
- Cryoport reports Q4 EPS (27c), consensus (21c)